Digistain (Seed)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$12,000,000

Company Info
Founders
Hemmel Amrania
Company Description
Developer of medical imaging platform intended to eliminate the overuse of cancer chemotherapy with a quick and affordable diagnostic test. Digistain uses infrared scanning to determine which breast cancer patients are fit for chemotherapy.
Market
Healthcare & Wellness
Coinvestors
Y Combinator

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement